Tag Archives: The Stem Cell Blog

The First CRISPR Studies for Inherited Disease Will Start Soon – MIT Technology Review

Continue reading

2017-12-07 NEWS

MIT Technology Review

The First CRISPR Studies for Inherited Disease Will Start Soon
MIT Technology Review
Biotech companies have been telling us for a while now that CRISPR, the gene-editing technology, can be shaped into a radically precise form of gene therapy—now one of them, CRISPR Therapeutics, says it’s ready to test the idea on people. The startup
CRISPR Therapeutics Submits First Clinical Trial Application for a …GlobeNewswire (press release)
Analyzing Arena Pharmaceuticals (ARNA) and Intellia Therapeutics (NTLA)StockNewsTimes
The Analysts Set Intellia Therapeutics Inc (NTLA) PT at $26.00BangaloreWeekly

all 8 news articles »

Continue reading

2017-12-07 NEWS

Stanford Medical Center Report

Stanford faculty receive grants from state stem cell agency
Stanford Medical Center Report
One award was meant to support translational research that has already shown early stage promise; the other two were smaller, proof-of-principle grants meant to allow researchers to test potentially important ideas in the stem cell field at the
Novel harvesting method rapidly produces superior stem cells for transplantationMedical Xpress
Stem cells ‘will enable us to live to 200’The Scotsman
North America Stem Cell Media Market by Hematopoietic, Mesenchymal, Pluripotent Type, Detail Analysis and …Medgadget (blog)
Expert Herald –MilTech –satPRnews (press release)
all 37 news articles »
Continue reading

2017-12-07 NEWS

Immunotherapy Response Influenced by Cancer Patients’ HLA Genotypes
GenomeWeb
NEW YORK (GenomeWeb) – Patients’ human leukocyte antigen (HLA) genotypes influence how well they respond to immunotherapy, according to a new study. HLA class I molecules bind peptides from intracellular proteins, including tumor proteins, and present

Continue reading

2017-12-07 NEWS

Immunotherapy Response Influenced by Cancer Patients’ HLA Genotypes
GenomeWeb
NEW YORK (GenomeWeb) – Patients’ human leukocyte antigen (HLA) genotypes influence how well they respond to immunotherapy, according to a new study. HLA class I molecules bind peptides from intracellular proteins, including tumor proteins, and present